MitoRx Therapeutics Strengthens Scientific Advisory Board with Appointment of Four International Experts
07 mars 2024 04h00 HE
|
MitoRx Therapeutics
OXFORD, United Kingdom, March 07, 2024 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the...
MitoRx Therapeutics Announces Close of Seed Extension Financing Round to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases
13 déc. 2023 03h00 HE
|
MitoRx Therapeutics
OXFORD, United Kingdom, Dec. 13, 2023 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the...
MitoRx Therapeutics Announces Scientific Advisory Board, Chief Development Officer and Finance Director
07 mars 2023 03h00 HE
|
MitoRx Therapeutics
OXFORD, England, March 07, 2023 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a biotechnology company developing revolutionary therapeutics that reverse mitochondrial dysfunction to arrest the...
Raptor Pharmaceutical to Present Data on QUINSAIR™ at European Cystic Fibrosis Conference
07 juin 2016 16h05 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., June 07, 2016 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company developing and commercializing transformative treatments for rare diseases,...
Raptor Pharmaceutical to Participate in the Cowen and Company 36th Annual Health Care Conference
01 mars 2016 07h30 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., March 01, 2016 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will participate in the following investor conference: Julie Anne Smith,...
Raptor Pharmaceutical to Participate in International Rare Disease Week Through Multiple Patient Advocacy Activities
29 févr. 2016 07h30 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced its support of Rare Disease Week, beginning February 29, 2016, with a series of activities...
Raptor Pharmaceutical Announces Management Changes
15 juil. 2015 07h30 HE
|
Raptor Pharmaceutical Inc
NOVATO, Calif., July 15, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced the appointment of Ashley Gould, J.D. as its Senior Vice President, General Counsel and...